EFNA3 (Cleaved-Gly214) rabbit pAb
- Catalog No.:YC0156
- Applications:WB;ELISA
- Reactivity:Human;Mouse;Rat
- Target:
- Ephrin-A3
- Fields:
- >>MAPK signaling pathway;>>Ras signaling pathway;>>Rap1 signaling pathway;>>PI3K-Akt signaling pathway;>>Axon guidance;>>MicroRNAs in cancer
- Gene Name:
- EFNA3 EFL2 EPLG3 LERK3
- Protein Name:
- EFNA3 (Cleaved-Gly214)
- Human Gene Id:
- 1944
- Human Swiss Prot No:
- P52797
- Mouse Gene Id:
- 13638
- Mouse Swiss Prot No:
- O08545
- Immunogen:
- Synthesized peptide derived from human EFNA3 (Cleaved-Gly214)
- Specificity:
- This antibody detects endogenous levels of Human,Mouse,Rat EFNA3 (Cleaved-Gly214, protein was cleaved amino acid sequence between 214-215 )
- Formulation:
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source:
- Polyclonal, Rabbit,IgG
- Dilution:
- WB 1:1000-2000 ELISA 1:5000-20000
- Purification:
- The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.
- Concentration:
- 1 mg/ml
- Storage Stability:
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Other Name:
- Ephrin-A3 (EFL-2;EHK1 ligand;EHK1-L;EPH-related receptor tyrosine kinase ligand 3;LERK-3)
- Observed Band(KD):
- 24kD
- Background:
- similarity:Belongs to the ephrin family.,tissue specificity:Expressed in brain, skeletal muscle, spleen, thymus, prostate, testis, ovary, small intestine, and peripheral blood leukocytes.,
- Function:
- cell-cell signaling,
- Subcellular Location:
- Cell membrane; Lipid-anchor, GPI-anchor.
- Expression:
- Expressed in brain, skeletal muscle, spleen, thymus, prostate, testis, ovary, small intestine, and peripheral blood leukocytes.
- June 19-2018
- WESTERN IMMUNOBLOTTING PROTOCOL
- June 19-2018
- IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL
- June 19-2018
- IMMUNOFLUORESCENCE PROTOCOL
- September 08-2020
- FLOW-CYTOMEYRT-PROTOCOL
- May 20-2022
- Cell-Based ELISA│解您多样本WB检测之困扰
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN
- July 13-2018
- Antibody-FAQs